Accolade to Participate in the 2022 SVB Leerink Global Healthcare Conference

2 years ago

SEATTLE, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves over 600 employers and…

Dyve Biosciences to Present at the 32nd Annual Oppenheimer Healthcare Conference

2 years ago

CAMARILLO, Calif., Feb. 16, 2022 (GLOBE NEWSWIRE) -- Dyve Biosciences, Inc. (“Dyve”), a clinical-stage biotech company applying its proprietary transdermal…

Fate Therapeutics to Webcast Conference Call Reporting Fourth Quarter and Full Year 2021 Financial Results

2 years ago

SAN DIEGO, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage biopharmaceutical…

Zephyr AI Appoints David L. Morgan as Chief Executive Officer

2 years ago

Morgan Tapped to Lead Company’s Mission to Disrupt Drug Discovery and Precision Medicine TYSONS, Va.--(BUSINESS WIRE)--Zephyr AI, Inc. (“Zephyr AI”),…

Electromed, Inc., Appoints Christopher Holland Chief Commercial Officer

2 years ago

Key appointment will guide the Company’s strategic growth initiatives NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed” or the “Company”) (NYSE American:…

Perimeter Medical Imaging AI Announces Conference Call and Webcast to Provide Corporate Update

2 years ago

Live Call/Webcast on Wednesday, February 23, 2022 at 5 pm ET TORONTO & DALLAS--(BUSINESS WIRE)--$PINK.V #AI--Perimeter Medical Imaging AI, Inc.…

Better Therapeutics Enrolls First Patient in Real World Evidence Study with Colorado Prevention Center Clinical Research

2 years ago

Open-label, randomized, controlled study will evaluate BT-001, a prescription digital therapeutic (PDT) delivering cognitive behavioral therapy to address behavioral root…

SimplePractice Partners with Smartlink Health Solutions to Enable Whole Patient Care in North Carolina

2 years ago

The partnership enables participation in North Carolina’s health information exchange (HIE) for thousands of SimplePractice customer practices serving clients using…

Defence Retains CATO SMS to Advise on Its Phase I Clinical Trial on AccuTOX(TM) for Breast Cancer

2 years ago

Vancouver, British Columbia--(Newsfile Corp. - February 16, 2022) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence"…

Interim Report January – December 2021

2 years ago

STOCKHOLM, SWEDEN / ACCESSWIRE / February 16, 2022 / Promore Pharma (STO:PROMO)(FRA:8T0)October to DecemberNet sales amounted to MSEK 0 (0)Net…